Cas No 315-30-0 Msds Allopurinol API Powder Xanthine Oxidase Inhibitor Antipyretic Analgesic Antigout

Basic Information
Place of Origin: China
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Your demand
Delivery Time: Negotiation
Payment Terms: D/P, D/A, L/C, T/T
Supply Ability: Negotiation
Cas No: 315-30-0 Ec No: 206-250-9
Name: Allopurinol Synonyms: 4-Hydroxypyrazolo[3,4-d]pyrimidine; 1H-Pyrazolo[3,4-d]pyrimidin-4-ol; HPP
Molecular Formula: C5H4N4O Molecular Weight: 136.11
Melting Point: >300 °C Boiling Point: 250.36°C
Solubility: 1 M NaOH: Soluble50mg/mL, Clear To Very Slightly Hazy, Colorless To Faintly Yellow Density: 1.4295 G/cm3
Risk Codes: R25-43-36/37/38-20/21/22 Safety Description: S28-36/37-45-36/37/39-26-24-36
High Light:

Allopurinol 315-30-0 Msds API


315-30-0 Msds API Allopurinol


API 315-30-0 Msds Allopurinol

Allopurinol Cas No 315-30-0 API; Antipyretic analgesic, antigout


Name Allopurinol
Synonyms 4-Hydroxypyrazolo[3,4-d]pyrimidine; 1H-Pyrazolo[3,4-d]pyrimidin-4-ol; HPP
Molecular Formula C5H4N4O
Molecular Weight 136.11
CAS Registry Number 315-30-0
EINECS Number 206-250-9
Melting point >300 °C
Boiling point 250.36°C
Solubility 1 M NaOH: soluble50mg/mL, clear to very slightly hazy, colorless to faintly yellow
Density 1.4295 g/cm3
Safety Description S28-36/37-45-36/37/39-26-24-36
Risk Codes R25-43-36/37/38-20/21/22


Product Description:


Allopurinol as white or white crystalline powder, odourless, almost don't Piao alcohol mainly between gout attack period and chronic use, suitable for uric acid to generate too much, for uric acid drug allergy or invalid, as well as the unfavorable use row of uric acid, primary and secondary gout patients to control high uric acid hematic disease, also can with uric acid fungicides, to enhance curative effect, It is especially suitable for patients with serious tophi and good renal function.


Product Use:


Anti-gout medicine. Suitable for primary or secondary serum uric acid increase in various diseases, such as gout, acute or chronic leukemia.


Cas No 315-30-0 Msds Allopurinol API Powder Xanthine Oxidase Inhibitor Antipyretic Analgesic Antigout 0Cas No 315-30-0 Msds Allopurinol API Powder Xanthine Oxidase Inhibitor Antipyretic Analgesic Antigout 1


Product Catalogue:


Number Cas Name
1 103-90-2 Acetaminophen
2 51481-61-9 Cimetidine
3 124832-26-4 Valaciclovir
4 315-30-0 Allopurinol
5 22839-47-0 Aspartame
6 90045-36-6 Ginkgo biloba extract
7 73-31-4 Melatonine
8 8049-47-6 Pancreatin
9 70-55-3 p-Toluenesulfonamide
10 N/A Ox Gallbladder powde
11 555-30-6 Methyldopa
12 58-93-5 Hydrochlorothiazide
13 76095-16-4 Enalapril maleate
14 69-72-7 Salicylic acid
15 126-07-8 (+)-Griseofulvin
16 73231-34-2 Florfenicol



About us



Zhejiang chemical import and export co., LTD. (zhejiang), formerly known as zhejiang branch of China national chemical import and export corporation, was established in December 1980. In 1988, he was transferred from Sinochem Corporation to be in charge of Zhejiang Provincial Department of Commerce and was renamed Zhejiang Chemical Import and Export Company. In 2003, the company changed its name to Zhejiang Chemical Import and Export Co., Ltd after the reform of state-owned enterprise shareholding system.

In 2008, it was incorporated into Zhejiang International Trade Group (one of the top 500 enterprises in China) and became the core member of the group's business circulation sector. The registered capital of the company is 72.5 million yuan, of which 38% are owned by the state and 62% are owned by employees.
There are 195 employees in the company, more than 79% of whom have bachelor's degree, 36% of whom are graduate students, and more than 90% of the salesmen have pharmaceutical and chemical background. The company is mainly engaged in the import and export trade of pharmaceutical raw materials and intermediates, dyes, pesticides, basic chemicals, fine chemicals, food and feed additives, pharmaceutical preparations and other products. The company has established close economic and trade relations with more than 100 countries and regions around the world. The company has wholly-owned subsidiaries Ruike International Trade Co., Ltd., Zhejiang Ruikai Chemical Co., Ltd., Zhejiang Fukai Import and Export Co., Ltd., joint-stock enterprise Zhejiang Aotokang Pharmaceutical Group Co., Ltd.
In recent years, especially since the establishment of the new team in 2019, the company has adhered to the development led by the party building, energized by reform, and improved efficiency by management. The company has shown a steady upward momentum of development. In 2020, the company achieved revenue of 3.337 billion yuan, total profit of 56.12 million yuan, total import and export of 450 million dollars.

In 2019, the company was rated as China Council for the Promotion of International Trade (CCPIT) Recommended Certification Enterprise, Top 100 International Pharmaceutical Enterprises -- a high-quality supplier and partner in the international market; In 2020, Zhejiang Provincial Department of Commerce and other units rated as the province's epidemic prevention and medical materials import outstanding contribution enterprise, Zhejiang Provincial Tax Bureau identified as the export tax rebate enterprises.


Contact Details
William Wang

Phone Number : +86-13588430486

WhatsApp : +8613588430486